Dr. Ramalingam on Pemetrexed and Bevacizumab as Maintenance Therapy for Advanced NSCLC

Cancer Network spoke with Suresh S. Ramalingam, MD, of Emory University, about  pemetrexed, bevacizumab, or both for advanced non-squamous NSCLC.

Source: CancerNetwork - June 11, 2019 Category: Cancer & Oncology Authors: Suresh S. Ramalingam, MD Source Type: news